Study for Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19)

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033320

Enrollment

Unknown

Registered

2020-05-27

Start date

2020-01-21

Completion date

Unknown

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Control:Guidelines for routine treatment

Therapy group:TCM

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Conform to the diagnostic criteria of Western Medicine's New Coronary Pneumonia; 2. Aged 18-65 years old male or female.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the diagnostic criteria for new coronary pneumonia; 2. Women who are pregnant or breastfeeding, who are allergic to this medicine; 3. Combining patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system, mental illness; 4. Contains factors that affect the observation of efficacy; 5. Those who do not meet the inclusion criteria, fail to use the prescribed drugs, and cannot determine the efficacy or incomplete data, etc., affect the efficacy or safety judgment.

Design outcomes

Primary

Measure	Time frame
Throat Swab Nucleic Acid Test;	—

Countries

China

Contacts

Public ContactZhang Wei

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

zhangw1190a@sina.com+86 13601733045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026